March 8, 2018 / 9:22 PM / 5 months ago

BRIEF-Pernix Therapeutics Reports Q4 Loss Per Share $2.78

March 8 (Reuters) - Pernix Therapeutics Holdings Inc :

* PERNIX THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

* Q4 REVENUE ROSE 38 PERCENT TO $41.5 MILLION

* Q4 LOSS PER SHARE $2.78 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below